Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical implications of tumor necrosis factor receptor 2 in breast cancer
Fuqian Yang, Zhonghua Zhao, Nana Zhao
Oncology Letters (2017) Vol. 14, Iss. 2, pp. 2393-2398
Open Access | Times Cited: 20

Showing 20 citing articles:

The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches
Daniel Cruceriu, Oana Baldasici, Ovidiu Bălăcescu, et al.
Cellular Oncology (2020) Vol. 43, Iss. 1, pp. 1-18
Closed Access | Times Cited: 359
Unleashing endogenous TNF-alpha as a cancer immunotherapeutic
Steven F. Josephs, Thomas E. Ichim, Stephen M. Prince, et al.
Journal of Translational Medicine (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 220
TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors
Yuqiao Sheng, Feng Li, Zhihai Qin
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 101
Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis
Ramy Gadalla, Hebatallah Hassan, Sherif Ibrahim, et al.
Breast Cancer Research and Treatment (2019) Vol. 174, Iss. 3, pp. 679-691
Closed Access | Times Cited: 48
Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy
Juliane Medler, Kirstin Kucka, Harald Wajant
Cancers (2022) Vol. 14, Iss. 11, pp. 2603-2603
Open Access | Times Cited: 27
The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
Hiroyuki Takahashi, Gumpei Yoshimatsu, Denise L. Faustman
Cells (2022) Vol. 11, Iss. 12, pp. 1952-1952
Open Access | Times Cited: 24
A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy
Mohammad A. I. Al-Hatamleh, Suhana Ahmad, Jennifer C. Boer, et al.
Journal of Oncology (2019) Vol. 2019, pp. 1-13
Open Access | Times Cited: 35
Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
Muchun Li, Xiaozhen Zhang, Xueli Bai, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
TNFR2 deficiency impairs the growth of mouse colon cancer
Ping Li, Yang Yang, Xinyu Yang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 4, pp. 1024-1035
Open Access | Times Cited: 8
The prognostic value of the C-reactive protein to albumin ratio in cancer
Xinhua Cui, Zhiqiang Jia, Dingchao Chen, et al.
Medicine (2020) Vol. 99, Iss. 14, pp. e19165-e19165
Open Access | Times Cited: 21
LINC00173 silence and estrone supply suppress ER+ breast cancer by estrogen receptor α degradation and LITAF activation
Yu Xie, Meihua Shan, Jing Yu, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2318-2332
Open Access | Times Cited: 2
Targeting TNFR2 for cancer immunotherapy: recent advances and future directions
Linxue Li, Ruiwei Ye, Yingying Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment
Mohammad A. I. Al-Hatamleh, Engku Nur Syafirah Engku Abd Rahman, Jennifer C. Boer, et al.
Cells (2019) Vol. 9, Iss. 1, pp. 33-33
Open Access | Times Cited: 19
Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer
Ali Mussa, Nor Hayati Ismail, Mahasin Hamid, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer
Qiang Fu, Qian Shen, J.J.H.M. Tong, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 8
High expression of tumor necrosis factor receptor 2 in tissue is associated with progression and prognosis of esophageal squamous cell carcinoma
Zifeng Liu, Changgeng Ma, Guohui Ma, et al.
Human Pathology (2018) Vol. 80, pp. 179-185
Closed Access | Times Cited: 7
Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation
Jinhee Lee, Steffanus Pranoto Hallis, Mi‐Kyoung Kwak
Archives of Pharmacal Research (2024) Vol. 47, Iss. 5, pp. 465-480
Closed Access
The expression of tumor necrosis factor receptor 2 is correlated with the prognosis of cancer: a systematic review and meta-analysis
Hyun Min Koh, Nayoung Han
Translational Cancer Research (2024) Vol. 13, Iss. 8, pp. 4231-4241
Open Access
Cytokine Profile in Lung Cancer Patients: Anti-tumor and Oncogenic Cytokines
Freddy Elad Essogmo, Zhilenkova Angelina V., Abah Moses Owoicho, et al.
(2023)
Open Access | Times Cited: 1
Aberrant frequency of TNFR2-expressing CD4+ FoxP3+ regulatory T cells in nasopharyngeal carcinoma patients
Engku Nur Syafirah Engku Abd Rahman, Ahmad Adebayo Irekeola, Rafidah Hanim Shueb, et al.
Cytokine (2023) Vol. 170, pp. 156341-156341
Closed Access
Page 1

Scroll to top